CURE vs. KURE

Last updated Jul 15, 2026

CURE (Direxion Daily Healthcare Bull 3x Shares) and KURE (KraneShares MSCI All China Health Care Index ETF) are both exchange-traded funds - CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%), while KURE is a China Equities fund tracking the MSCI China All Shares Health Care 10/40 Index. Both are passively managed. Over the past 5 years, CURE returned 1.16%/yr vs -13.95%/yr for KURE. At a 0.23 correlation, their price movements are largely independent. CURE charges 1.08%/yr vs 0.65%/yr for KURE.

Performance

CURE vs. KURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and KraneShares MSCI All China Health Care Index ETF (KURE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CURE achieves a -0.14% return, which is significantly lower than KURE's 1.06% return.

CURE

• 1D: -5.67%
• 1M: 8.49%
• 6M: -3.29%
• YTD: -0.14%
• 1Y: 42.28%
• 3Y*: 5.85%
• 5Y*: 1.16%
• 10Y*: 13.12%

KURE

• 1D: 2.14%
• 1M: 13.45%
• 6M: -10.59%
• YTD: 1.06%
• 1Y: 1.17%
• 3Y*: -0.32%
• 5Y*: -13.95%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE vs. KURE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
CURE Direxion Daily Healthcare Bull 3x Shares	-0.14%	22.55%	-8.47%	-9.40%	-20.51%	88.30%	5.02%	55.66%	-14.36%
KURE KraneShares MSCI All China Health Care Index ETF	1.06%	24.87%	-17.83%	-17.70%	-25.43%	-16.01%	68.97%	34.30%	-30.01%

Correlation

The correlation between CURE and KURE is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.13
Correlation (3Y) Calculated over the trailing 3-year period	0.16
Correlation (5Y) Calculated over the trailing 5-year period	0.17
Correlation (All Time) Calculated using the full available price history since Feb 1, 2018	0.23

CURE vs. KURE - Sectors Allocation Comparison

Sectors	CURE	KURE
Healthcare	100.0%	99.3%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	0.7%
Energy	-	-
Financial Services	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

CURE vs. KURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CURE

CURE Risk / Return Rank: 32
CURE Sharpe Ratio Rank: 31
CURE Sortino Ratio Rank: 36
CURE Omega Ratio Rank: 31
CURE Calmar Ratio Rank: 33
CURE Martin Ratio Rank: 28

KURE

KURE Risk / Return Rank: 10
KURE Sharpe Ratio Rank: 10
KURE Sortino Ratio Rank: 10
KURE Omega Ratio Rank: 10
KURE Calmar Ratio Rank: 10
KURE Martin Ratio Rank: 10

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE vs. KURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and KraneShares MSCI All China Health Care Index ETF (KURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CURE	KURE	Difference
Sharpe ratio: Return per unit of total volatility	0.91	0.04	+0.87
Sortino ratio: Return per unit of downside risk	1.59	0.26	+1.33
Omega ratio: Gain probability vs. loss probability	1.18	1.03	+0.15
Calmar ratio: Return relative to maximum drawdown	1.37	0.04	+1.33
Martin ratio: Return relative to average drawdown	3.04	0.08	+2.97

CURE vs. KURE - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is 0.91, which is higher than the KURE Sharpe Ratio of 0.04. The chart below compares the historical Sharpe Ratios of CURE and KURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CURE vs. KURE - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, roughly equal to the maximum KURE drawdown of -68.53%. Use the drawdown chart below to compare losses from any high point for CURE and KURE.

Drawdown Indicators

	CURE	KURE	Difference
Max Drawdown Largest peak-to-trough decline	-69.19%	-68.53%	-0.66%
Max Drawdown (1Y) Largest decline over 1 year	-31.10%	-30.88%	-0.22%
Max Drawdown (3Y) Largest decline over 3 years	-51.93%	-34.05%	-17.88%
Max Drawdown (5Y) Largest decline over 5 years	-52.23%	-66.18%	+13.95%
Max Drawdown (10Y) Largest decline over 10 years	-69.19%	—	—
Current Drawdown Current decline from peak	-20.74%	-56.00%	+35.26%
Average Drawdown Average peak-to-trough decline	-18.17%	-38.33%	+20.16%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.95%	15.60%	-1.65%

Volatility

CURE vs. KURE - Volatility Comparison

Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 18.02% compared to KraneShares MSCI All China Health Care Index ETF (KURE) at 10.46%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than KURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CURE	KURE	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.02%	10.46%	+7.56%
Volatility (6M) Calculated over the trailing 6-month period	34.09%	19.74%	+14.35%
Volatility (1Y) Calculated over the trailing 1-year period	46.74%	27.76%	+18.98%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.47%	31.91%	+12.56%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	49.72%	32.42%	+17.30%

CURE vs. KURE - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is higher than KURE's 0.65% expense ratio.

Dividends

CURE vs. KURE - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.14%, less than KURE's 4.15% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
CURE Direxion Daily Healthcare Bull 3x Shares	1.14%	1.12%	1.17%	2.02%	0.38%	0.02%	0.17%	0.40%	0.70%	0.18%
KURE KraneShares MSCI All China Health Care Index ETF	4.15%	4.19%	1.29%	0.65%	0.05%	14.12%	0.00%	0.25%	0.21%	0.00%

Frequently Asked Questions

Can I hold both CURE and KURE in my portfolio?

CURE and KURE have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CURE or KURE?

CURE has higher volatility (18.02%) compared to KURE (10.46%). In terms of maximum drawdown, CURE dropped -69.19% vs KURE's -68.53%.

Which ETF is better, CURE or KURE?

On 5-year performance, CURE leads with 1.16% vs -13.95% for KURE. On fees, KURE is cheaper at 0.65% per year. On volatility, KURE has been the lower-risk option at 10.46%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, CURE or KURE?

Over the 5-year period, CURE has performed better with a 1.16% return vs -13.95%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, CURE or KURE?

KURE is cheaper with a 0.65% expense ratio, compared with 1.08% for CURE.

Which ETF pays a higher dividend yield, CURE or KURE?

KURE has the higher dividend yield at 4.15%, compared with 1.14% for CURE.

What is the main difference between CURE and KURE?

CURE is categorized as Leveraged Equities, while KURE is China Equities. CURE tracks Health Care Select Sector Index (300%), while KURE tracks MSCI China All Shares Health Care 10/40 Index. They also come from different issuers: Direxion and CICC. Their fees differ too: 1.08% for CURE and 0.65% for KURE.

Which has better risk-adjusted returns?

CURE currently has the higher Sharpe Ratio (0.91 vs 0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.